Management of Helicobacter pylori infection is evolving and in this 4th edition of the
Maastricht consensus report aspects related to the clinical role of H pylori were looked at …

H. pylori is one of the most common bacterial infections in human beings, and its discovery
20 years ago altered the diagnosis and treatment of gastroduodenal disease. This review …

Important progress has been made in the management of Helicobacter pylori infection and
in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role …

Objective The best approach for Helicobacter pylori management remains unclear. An audit
process is essential to ensure clinical practice is aligned with best standards of care. Design …

Helicobacter pylori (H. pylori) remains a prevalent, worldwide, chronic infection. Though the
prevalence of this infection appears to be decreasing in many parts of the world, H. pylori …

The K orean C ollege of H elicobacter and U pper G astrointestinal R esearch first
developed guidelines for the diagnosis and treatment of H elicobacter pylori (H. pylori) …

Background Thousands of systematic reviews have been conducted in all areas of health
care. However, the methodological quality of these reviews is variable and should routinely …

Background The optimal duration for Helicobacter pylori (H. pylori) eradication therapy is
controversial, with recommendations ranging from 7 to 14 days. Several systematic reviews …

Background & Aims Due to the poor eradication rates of standard triple therapy, the addition
of bismuth salts has been proposed for first-line eradication of Helicobacter pylori. We …

Over the past few decades, since the introduction of histamine H2-receptor antagonists,
proton-pump inhibitors, cyclo-oxygenase-2-selective anti-inflammatory drugs (coxibs), and …